{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:19:43Z","timestamp":1787239183966,"version":"build-2736575974"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003835","name":"I-Shou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TB114008"],"award-info":[{"award-number":["KMU-TB114008"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC114A08"],"award-info":[{"award-number":["KMU-TC114A08"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B-214-002"],"award-info":[{"award-number":["NSTC113-2314-B-214-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2320-B-037-011-MY3"],"award-info":[{"award-number":["NSTC113-2320-B-037-011-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2735-B-001-001"],"award-info":[{"award-number":["NSTC114-2735-B-001-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuint.2025.106104","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:17:21Z","timestamp":1765725441000},"page":"106104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance"],"prefix":"10.1016","volume":"192","author":[{"given":"Yi-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Chen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Lin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoth Kumar","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel Ali","family":"Belaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-0987","authenticated-orcid":false,"given":"Liang-Yin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2025.106104_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of Alzheimer's disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2025.106104_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and Alzheimer's disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2025.106104_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: tau pathology is an initiating factor in sporadic Alzheimer's disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106104_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/JMN:23:3:157","article-title":"APOE genotype effects on Alzheimer's disease onset and epidemiology","volume":"23","author":"Ashford","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4103\/NRR.NRR-D-23-01770","article-title":"Role of metabolic dysfunction and inflammation along the liver-brain axis in animal models with obesity-induced neurodegeneration","volume":"20","author":"Asimakidou","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuint.2025.106104_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s12031-013-9979-6","article-title":"FTY720 (fingolimod) attenuates beta-amyloid peptide (Abeta42)-induced impairment of spatial learning and memory in rats","volume":"50","author":"Asle-Rousta","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s42003-022-04011-6","article-title":"Multi-omic analyses characterize the ceramide\/sphingomyelin pathway as a therapeutic target in Alzheimer's disease","volume":"5","author":"Baloni","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuint.2025.106104_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","article-title":"ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain","volume":"30","author":"Bandaru","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2025.106104_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000484621","article-title":"Blockade of experimental multiple sclerosis by inhibition of the acid sphingomyelinase\/ceramide system","volume":"25","author":"Becker","year":"2017","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuint.2025.106104_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-025-00843-y","article-title":"Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities","volume":"20","author":"Belaidi","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41380-022-01568-w","article-title":"Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy","volume":"29","author":"Belaidi","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2025.106104_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","article-title":"Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease","volume":"52","author":"Bierer","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.14336\/AD.2014.002","article-title":"Metabolic risk factors of sporadic Alzheimer's disease: implications in the pathology, pathogenesis and treatment","volume":"6","author":"Chakrabarti","year":"2015","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1471-4159.1998.70020708.x","article-title":"Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice","volume":"70","author":"Chapman","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2025.106104_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","article-title":"Ceramides in metabolism: key lipotoxic players","volume":"83","author":"Chaurasia","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuint.2025.106104_bib18","article-title":"Apolipoprotein E knockout may affect cognitive function in D-galactose-induced aging mice through the gut microbiota-brain axis","volume":"16","author":"Chen","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib19","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cmet.2019.04.009","article-title":"Temporal control of appetite by AgRP clocks","volume":"29","author":"Chen","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuint.2025.106104_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","article-title":"Tau PET in Alzheimer disease and mild cognitive impairment","volume":"87","author":"Cho","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2025.106104_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s12276-024-01176-4","article-title":"Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease","volume":"56","author":"Choi","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081956","article-title":"Diverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease","volume":"10","author":"Chowdhury","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2025.106104_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cmet.2023.03.022","article-title":"Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation","volume":"35","author":"Chung","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuint.2025.106104_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2025.106104_bib26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3389\/fneur.2019.01152","article-title":"Lipid-binding proteins in brain health and disease","volume":"10","author":"Corraliza-Gomez","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123233","article-title":"Inflammatory pathways in overweight and Obese persons as a potential mechanism for cognitive impairment and earlier onset Alzeihmer's dementia in the general population: a narrative review","volume":"11","author":"Costache","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2025.106104_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20070040","article-title":"A reversible form of lysine acetylation in the ER and golgi lumen controls the molecular stabilization of BACE1","volume":"407","author":"Costantini","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2025.106104_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20050700","article-title":"A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging","volume":"391","author":"Costantini","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2025.106104_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2019.12.003","article-title":"Sphingolipids in Alzheimer's disease, how can we target them?","volume":"159","author":"Crivelli","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuint.2025.106104_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113240","article-title":"FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4","volume":"152","author":"Crivelli","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuint.2025.106104_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76335-4","article-title":"Ceramide analog [(18)F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer's disease transgenic mice by functioning as a metabolic probe","volume":"10","author":"Crivelli","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106104_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14283\/jpad.2022.34","article-title":"Aducanumab: appropriate use recommendations update","volume":"9","author":"Cummings","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158082","article-title":"Ceramide\/sphingosine 1-Phosphate axis as a key target for diagnosis and treatment in Alzheimer's disease and other neurodegenerative diseases","volume":"23","author":"Custodia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106104_bib36","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106104_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-013-8606-4","article-title":"Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate","volume":"50","author":"Czubowicz","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106104_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11357-023-00989-x","article-title":"Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer's disease","volume":"46","author":"Dakterzada","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.neuint.2025.106104_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410250506","article-title":"Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease","volume":"25","author":"de la Monte","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib40","first-page":"171","article-title":"Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases","volume":"54","author":"De La Monte","year":"2012","journal-title":"Panminerva Med."},{"issue":"Suppl. 2","key":"10.1016\/j.neuint.2025.106104_bib41","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3233\/JAD-2012-111727","article-title":"Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib42","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/ijerph6072055","article-title":"The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids","volume":"6","author":"de la Monte","year":"2009","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.neuint.2025.106104_bib43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3233\/JAD-2010-091726","article-title":"Ceramide-mediated insulin resistance and impairment of cognitive-motor functions","volume":"21","author":"de la Monte","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106104_bib45","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/acschemneuro.8b00556","article-title":"Inhibition of serine palmitoyltransferase by a small organic molecule promotes neuronal survival after astrocyte amyloid beta 1-42 injury","volume":"10","author":"De Vita","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib46","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.18632\/aging.102810","article-title":"Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials","volume":"12","author":"Den","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuint.2025.106104_bib47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/ADR220072","article-title":"Sphingolipids in cerebrospinal fluid and plasma lipoproteins of APOE4 homozygotes and Non-APOE4 carriers with mild cognitive impairment versus subjective cognitive decline","volume":"7","author":"den Hoedt","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.neuint.2025.106104_bib48","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/ejn.12235","article-title":"Amyloid-beta protein (Abeta) Glu11 is the major beta-secretase site of beta-site amyloid-beta precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to abeta Asp1 contributes to Alzheimer pathogenesis","volume":"37","author":"Deng","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.neuint.2025.106104_bib50","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2025.106104_bib51","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","article-title":"Neutral Sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD mouse","volume":"36","author":"Dinkins","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib52","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","article-title":"Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins","volume":"271","author":"Dong","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106446","article-title":"Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3beta inhibitors for the treatment of Alzheimer's disease","volume":"134","author":"Dong","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib54","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/1567205013666160314150501","article-title":"Molecular basis of familial and sporadic Alzheimer's disease","volume":"13","author":"Dorszewska","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2025.106104_bib55","series-title":"Introduction to Lipids and Lipoproteins","author":"Feingold","year":"2000"},{"key":"10.1016\/j.neuint.2025.106104_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases","volume":"17","author":"Fernandez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124481","article-title":"Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties","volume":"10","author":"Figuera-Losada","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106104_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125597","article-title":"Sphingolipid metabolism correlates with cerebrospinal fluid beta amyloid levels in Alzheimer's disease","volume":"10","author":"Fonteh","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106104_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/STROKEAHA.118.023788","article-title":"Blood-brain barrier leakage and microvascular lesions in cerebral amyloid angiopathy","volume":"50","author":"Freeze","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2025.106104_bib61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of caveolin, clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuint.2025.106104_bib62","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41593-024-01763-8","article-title":"Synergistic association of abeta and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults","volume":"27","author":"Gallego-Rudolf","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/gut.2009.202515","article-title":"Bacterial infection causes stress-induced memory dysfunction in mice","volume":"60","author":"Gareau","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.neuint.2025.106104_bib64","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2025.106104_bib65","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.neurobiolaging.2013.02.001","article-title":"Inhibition of serine palmitoyltransferase reduces abeta and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease","volume":"34","author":"Geekiyanage","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2025.106104_bib66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)12007-Q","article-title":"Phosphorylation of tau in apolipoprotein E-deficient mice","volume":"199","author":"Genis","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2025.106104_bib67","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106104_bib68","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1038\/s41467-020-18198-x","article-title":"Association of APOE e2 genotype with Alzheimer's and non-alzheimer's neurodegenerative pathologies","volume":"11","author":"Goldberg","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106104_bib69","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2025.106104_bib70","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","article-title":"Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain","volume":"21","author":"Grehan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib71","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-beta and tau proteins in Alzheimer's disease: confuting the amyloid Cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuint.2025.106104_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","article-title":"Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications","volume":"20","author":"He","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2025.106104_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib76","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1264\/jsme2.ME17017","article-title":"Microbial ecology along the gastrointestinal tract","volume":"32","author":"Hillman","year":"2017","journal-title":"Microb. Environ."},{"key":"10.1016\/j.neuint.2025.106104_bib77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuint.2025.106104_bib78","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1570159X18666200503023323","article-title":"Is it the twilight of BACE1 inhibitors?","volume":"19","author":"Hrabinova","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2025.106104_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib80","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/13543784.2019.1683160","article-title":"Investigational BACE inhibitors for the treatment of Alzheimer's disease","volume":"28","author":"Imbimbo","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2025.106104_bib81","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106104_bib82","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106104_bib83","doi-asserted-by":"crossref","first-page":"51451","DOI":"10.1074\/jbc.M404635200","article-title":"Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease","volume":"279","author":"Jana","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/346783","article-title":"Ceramides in Alzheimer's disease: key mediators of neuronal apoptosis induced by oxidative stress and abeta accumulation","volume":"2015","author":"Jazvinscak Jembrek","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuint.2025.106104_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-beta peptides in Alzheimer's disease: a systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuint.2025.106104_bib86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2017.07.006","article-title":"Sodium selenate activated Wnt\/beta-catenin signaling and repressed amyloid-beta formation in a triple transgenic mouse model of Alzheimer's disease","volume":"297","author":"Jin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib87","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41467-020-16274-w","article-title":"Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels","volume":"11","author":"Johnson","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106104_bib88","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41579-018-0014-3","article-title":"Why does the microbiome affect behaviour?","volume":"16","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.neuint.2025.106104_bib89","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","article-title":"Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner","volume":"64","author":"Johnson","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib90","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-160645","article-title":"Association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer's disease","volume":"60","author":"Kim","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuint.2025.106104_bib92","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev.physiol.60.1.643","article-title":"Regulation of ceramide production and apoptosis","volume":"60","author":"Kolesnick","year":"1998","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuint.2025.106104_bib93","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2025.106104_bib94","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0306-4522(99)00061-5","article-title":"Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice","volume":"92","author":"Krzywkowski","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106104_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.954980","article-title":"ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways","volume":"13","author":"Kundu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106104_bib96","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3233\/JAD-215205","article-title":"Isoform-dependent effects of apolipoprotein E on sphingolipid metabolism in neural cells","volume":"85","author":"Kurano","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2022.11.018","article-title":"The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles","volume":"363","author":"Lahelma","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neuint.2025.106104_bib98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.2022.24494","article-title":"Lecanemab gains FDA approval for early alzheimer disease","volume":"329","author":"Larkin","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2025.106104_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086956","article-title":"Untargeted lipidomic profiling reveals lysophosphatidylcholine and ceramide as atherosclerotic risk factors in apolipoprotein E knockout mice","volume":"24","author":"Law","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106104_bib100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib101","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00702-023-02618-5","article-title":"Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?","volume":"130","author":"Lessmann","year":"2023","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neuint.2025.106104_bib102","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/ATVBAHA.112.301193","article-title":"Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuint.2025.106104_bib103","article-title":"An increased aspartate to alanine aminotransferase ratio is associated with a higher risk of cognitive impairment","volume":"9","author":"Li","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.abb.2003.08.031","article-title":"Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase","volume":"419","author":"Lightle","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuint.2025.106104_bib105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuint.2025.106104_bib106","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","article-title":"Hyperphosphorylation renders tau prone to aggregate and to cause cell death","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106104_bib107","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-024-06530-y","article-title":"The relevance between abnormally elevated serum ceramide and cognitive impairment in Alzheimer's disease model mice and its mechanism","volume":"241","author":"Liu","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuint.2025.106104_bib108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12967-023-04137-z","article-title":"Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-024-00720-0","article-title":"Gut microbiota-host lipid crosstalk in Alzheimer's disease: implications for disease progression and therapeutics","volume":"19","author":"Luo","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib111","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-2009-0984","article-title":"Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis","volume":"16","author":"Lyn-Cook","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib112","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2025.106104_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148793","article-title":"Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?","volume":"1829","author":"Manoharan","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2025.106104_bib114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib115","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1074\/jbc.M212262200","article-title":"Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism","volume":"278","author":"Marchesini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib116","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.31123","article-title":"Letter to the editor: coinfection of human immunodeficiency virus with hepatitis C virus: a change of paradigm","volume":"72","author":"Marcon","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.neuint.2025.106104_bib117","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/exnr.1995.1088","article-title":"Neurodegeneration in the central nervous system of apoE-deficient mice","volume":"136","author":"Masliah","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib118","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/acn3.50973","article-title":"Circulating ceramide ratios and risk of vascular brain aging and dementia","volume":"7","author":"McGrath","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1243132","article-title":"Sphingolipid metabolism in brain insulin resistance and neurological diseases","volume":"14","author":"Mei","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neuint.2025.106104_bib120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","article-title":"Ceramide function in the brain: when a slight tilt is enough","volume":"70","author":"Mencarelli","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2025.106104_bib121","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","article-title":"Serum ceramides increase the risk of Alzheimer disease: the Women's health and aging study II","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2025.106104_bib122","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/clp.12.59","article-title":"Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?","volume":"7","author":"Mielke","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.neuint.2025.106104_bib123","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-160925","article-title":"The association between plasma ceramides and sphingomyelins and risk of Alzheimer's disease differs by sex and APOE in the Baltimore longitudinal study of aging","volume":"60","author":"Mielke","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib124","series-title":"The Mevalonate Pathway in Alzheimer's Disease \u2014 Cholesterol and Non-sterol Isoprenoids","author":"Mohamed","year":"2015"},{"key":"10.1016\/j.neuint.2025.106104_bib125","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.febslet.2005.02.018","article-title":"Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E","volume":"579","author":"Morita","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2025.106104_bib126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2008-15103","article-title":"Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus","volume":"15","author":"Moroz","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106213","article-title":"Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice","volume":"184","author":"Mowry","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib128","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.14283\/jpad.2023.2","article-title":"Pharmacological inventions for alzheimer treatment in the United States of America: a revision patent from 2010 - 2020","volume":"10","author":"Navarro-Gomez","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib130","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib131","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1021\/bi1017655","article-title":"Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4","volume":"49","author":"Nguyen","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2025.106104_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bpa.12902","article-title":"Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease","volume":"31","author":"Ohm","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2025.106104_bib133","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3233\/JAD-170764","article-title":"Geographical distribution and diversity of gut microbial NADH:Ubiquinone oxidoreductase sequence associated with Alzheimer's disease","volume":"61","author":"Paley","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1348410","article-title":"A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer's disease, and their co-morbidities","volume":"15","author":"Pan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106104_bib135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13543784.2023.2233892","article-title":"Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies","volume":"32","author":"Panza","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2025.106104_bib136","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115082119","article-title":"Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer's disease mice","volume":"119","author":"Park","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106104_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175030","article-title":"Plasma lipidomics approach in early and specific Alzheimer's disease diagnosis","volume":"11","author":"Pena-Bautista","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib138","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.1074\/jbc.M300466200","article-title":"Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis","volume":"278","author":"Puglielli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143564","article-title":"Alteration of sphingolipids in biofluids: implications for neurodegenerative diseases","volume":"20","author":"Pujol-Lereis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106104_bib140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s43657-023-00098-x","article-title":"Genetic phenotypes of Alzheimer's disease: mechanisms and potential therapy","volume":"3","author":"Quan","year":"2023","journal-title":"Phenomics"},{"issue":"12","key":"10.1016\/j.neuint.2025.106104_bib195","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuint.2025.106104_bib141","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib142","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-021-03098-6","article-title":"Interactions of lipids, lipoproteins, and apolipoproteins with the blood-brain barrier","volume":"38","author":"Rhea","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2025.106104_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-beta precursor protein functions as a GABA(B)R1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neuint.2025.106104_bib144","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuint.2025.106104_bib145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0306-4522(97)00284-4","article-title":"Age-related congophilic inclusions in the brains of apolipoprotein E-deficient mice","volume":"82","author":"Robertson","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106104_bib146","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","article-title":"APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway","volume":"8","author":"Sando","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib147","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuroscience.2004.08.056","article-title":"Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis","volume":"130","author":"Satoi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106104_bib148","first-page":"43","article-title":"Plasma sphingolipid changes with autopsy-confirmed lewy body or Alzheimer's pathology","volume":"3","author":"Savica","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106104_bib149","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1096\/fj.12-222216","article-title":"Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1","volume":"27","author":"Schreurs","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2025.106104_bib150","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(92)90553-O","article-title":"TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced \"acidic\" sphingomyelin breakdown","volume":"71","author":"Schutze","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2025.106104_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040742","article-title":"Addressing blood-brain barrier impairment in Alzheimer's disease","volume":"10","author":"Sharma","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2025.106104_bib152","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106104_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/nu15214661","article-title":"Lipids, gut microbiota, and the complex relationship with Alzheimer's disease: a narrative review","volume":"15","author":"Simao","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.neuint.2025.106104_bib154","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuint.2025.106104_bib155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03014460600594513","article-title":"APOE distribution in world populations with new data from India and the UK","volume":"33","author":"Singh","year":"2006","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.neuint.2025.106104_bib156","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-181089","article-title":"Putative survival advantages in young apolipoprotein varepsilon4 carriers are associated with increased neural stress","volume":"68","author":"Smith","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib157","article-title":"Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106104_bib158","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106104_bib159","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/aps.2010.87","article-title":"Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells","volume":"31","author":"Sun","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuint.2025.106104_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064050","article-title":"FTY720\/fingolimod, a sphingosine analogue, reduces amyloid-beta production in neurons","volume":"8","author":"Takasugi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106104_bib161","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40035-023-00383-9","article-title":"Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model","volume":"12","author":"Tallon","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106104_bib162","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-200964","article-title":"Cerebrospinal fluid C18 ceramide associates with markers of Alzheimer's disease and inflammation at the Pre- and early stages of dementia","volume":"81","author":"Teitsdottir","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib163","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/glia.24329","article-title":"Early microglial response, myelin deterioration and lethality in mice deficient for very long chain ceramide synthesis in oligodendrocytes","volume":"71","author":"Teo","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.neuint.2025.106104_bib164","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuint.2025.106104_bib165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2025.106104_bib166","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-2009-0983","article-title":"Mechanisms of ceramide-mediated neurodegeneration","volume":"16","author":"Tong","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31756-0","article-title":"Particular CSF sphingolipid patterns identify iNPH and AD patients","volume":"8","author":"Torretta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106104_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147806","article-title":"Ceramide and Sphingosine-1-Phosphate in neurodegenerative disorders and their potential involvement in therapy","volume":"23","author":"Tringali","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2025.106104_bib169","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"12","author":"Troutwine","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neuint.2025.106104_bib170","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-4159.2007.05001.x","article-title":"Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line","volume":"104","author":"Udan","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2025.106104_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1368839","article-title":"Alzheimer's disease manifests abnormal sphingolipid metabolism","volume":"16","author":"Uranbileg","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib172","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-beta-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib173","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","article-title":"Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes","volume":"124","author":"van Doorn","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2025.106104_bib174","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2025.106104_bib175","article-title":"Plasma ceramides relate to mild cognitive impairment in middle-aged men: the maastricht study","volume":"15","author":"van Kruining","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106104_bib176","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1358\/dot.2010.46.5.1497556","article-title":"Oral fingolimod for the treatment of relapsing-remitting multiple sclerosis","volume":"46","author":"Vasiliou","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.neuint.2025.106104_bib177","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3233\/JAD-230164","article-title":"Effect of lecanemab in early Alzheimer's disease: mechanistic interpretation in the amyloid Cascade hypothesis 2.0 perspective","volume":"93","author":"Volloch","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib178","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4155\/fmc.11.47","article-title":"Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease","volume":"3","author":"Voronkov","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.neuint.2025.106104_bib179","doi-asserted-by":"crossref","first-page":"453","DOI":"10.14283\/jpad.2023.27","article-title":"Outreach, screening, and randomization of APOE epsilon4 carriers into an Alzheimer's prevention trial: a global perspective from the API generation program","volume":"10","author":"Walsh","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.neuint.2025.106104_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116071","article-title":"The function of sphingolipids in different pathogenesis of Alzheimer's disease: a comprehensive review","volume":"171","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuint.2025.106104_bib182","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12883-019-1591-0","article-title":"Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease","volume":"20","author":"Wattmo","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuint.2025.106104_bib183","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium Bis(Hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer's disease: cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib184","doi-asserted-by":"crossref","first-page":"780","DOI":"10.14283\/jpad.2022.63","article-title":"Oral tau aggregation inhibitor for Alzheimer's disease: design, progress and basis for selection of the 16 mg\/day dose in a phase 3, randomized, placebo-controlled trial of hydromethylthionine mesylate","volume":"9","author":"Wischik","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib185","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/brain\/awad135","article-title":"Age-related and amyloid-beta-independent tau deposition and its downstream effects","volume":"146","author":"Wuestefeld","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2025.106104_bib186","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3233\/JAD-151158","article-title":"Plasma ceramides and neuropsychiatric symptoms of Alzheimer's disease","volume":"52","author":"Xing","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106104_bib187","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib188","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ab.2007.09.005","article-title":"Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor","volume":"372","author":"Yamamoto","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2025.106104_bib189","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1096\/fj.201900604R","article-title":"High molecular weight amyloid beta(1-42) oligomers induce neurotoxicity via plasma membrane damage","volume":"33","author":"Yasumoto","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2025.106104_bib190","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2025.106104_bib191","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuint.2025.106104_bib192","article-title":"Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106104_bib193","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1523\/JNEUROSCI.0340-17.2017","article-title":"BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer's pathogenesis","volume":"37","author":"Zhang","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106104_bib194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002063","article-title":"A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Genet."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:51:08Z","timestamp":1768935068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":194,"alternative-id":["S0197018625001779"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106104","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106104"}}